VivoSim Labs, Inc. (LON:0R02)
London · Delayed Price · Currency is GBP · Price in USD 0.2645
+0.0054 (2.08%)
Mar 20, 2025, 5:32 PM GMT
VivoSim Labs Market Cap
VivoSim Labs has a market cap or net worth of 3.67 million as of February 12, 2026. Its market cap has decreased by -16.10% in one year.
Market Cap
3.67M
Enterprise Value
1.12M
Revenue
105.51K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
Market Cap Chart
Since February 14, 2012, VivoSim Labs's market cap has decreased from 36.80M to 3.67M, a decrease of -90.03%. That is a compound annual growth rate of -15.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.67M | 4.64% |
| Dec 31, 2025 | 3.51M | -37.87% |
| Dec 31, 2024 | 5.64M | -33.94% |
| Dec 29, 2023 | 8.55M | -16.20% |
| Dec 30, 2022 | 10.20M | -56.31% |
| Dec 31, 2021 | 23.34M | -61.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genflow Biosciences | 9.38M |
| OptiBiotix Health | 7.64M |
| Futura Medical | 7.57M |
| CRISM Therapeutics | 7.37M |
| Cizzle Biotechnology Holdings | 6.14M |
| Nuformix | 5.06M |
| Theracryf | 4.51M |
| ValiRx | 2.49M |